Liver International logo Blackwell Publishing logo

Publisher: Blackwell Publishing

Volume 29, Supplement 1, January 2009
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

< previous issue | next issue > | all issues

Hepatitis B and hepatitis C in 2009
pp. 1-8(8)
Author: Marcellin, Patrick

How to use virological tools for optimal management of chronic hepatitis C
pp. 9-14(6)
Authors: Chevaliez, Stéphane; Pawlotsky, Jean-Michel

What are the comorbidities influencing the management of patients and the response to therapy in chronic hepatitis C?
pp. 15-18(4)
Author: Alberti, Alfredo

Assessment of hepatitis C: non-invasive fibrosis markers and/or liver biopsy
pp. 19-22(4)
Author: Bedossa, Pierre

Optimal therapy in genotype 1 patients
pp. 23-30(8)
Authors: Farnik, Harald; Mihm, Ulrike; Zeuzem, Stefan

Optimizing the treatment of chronic hepatitis due to hepatitis C virus genotypes 2 and 3: a review
pp. 31-38(8)
Authors: Tarantino, Giuseppe; Craxì, Antonio

Hepatitis C genotype 4 therapy: increasing options and improving outcomes
pp. 39-48(10)
Author: Kamal, Sanaa M.

Retreatment of chronic hepatitis C: who and how?
pp. 49-56(8)
Author: Heathcote, Jenny

Protease and polymerase inhibitors for the treatment of hepatitis C
pp. 57-67(11)
Authors: Asselah, Tarik; Benhamou, Yves; Marcellin, Patrick

What future for ribavirin?
pp. 68-73(6)
Author: Shiffman, Mitchell L.

The global burden of hepatitis C
pp. 74-81(8)
Author: Lavanchy, Daniel

Discovery of the hepatitis C virus
pp. 82-88(7)
Author: Houghton, Michael

The history of the “natural history” of hepatitis C (1968-2009)
pp. 89-99(11)
Author: Seeff, Leonard B.

Natural history of chronic hepatitis B virus infection and long-term outcome under treatment
pp. 100-107(8)
Author: Liaw, Yun-Fan

Management and prevention of drug resistance in chronic hepatitis B
pp. 108-115(8)
Authors: Zoulim, Fabien; Durantel, David; Deny, Paul

Treatment of HBeAg-positive patients with nucleos/tide analogues
pp. 116-124(9)
Authors: Coffin, Carla S.; Lee, Samuel S.

HBeAg-positive chronic hepatitis B: why do I treat my patients with pegylated interferon
pp. 125-129(5)
Author: Lau, George K. K.

HBeAg-negative chronic hepatitis B: why do I treat my patients with nucleos(t)ide analogues
pp. 130-132(3)
Authors: Lampertico, Pietro; Colombo, Massimo

Hepatitis B and pregnancy: an underestimated issue
pp. 133-139(7)
Author: Jonas, Maureen M.

Hepatitis D: the comeback?
pp. 140-142(3)
Author: Rizzetto, Mario

Screening and diagnosis of hepatocellular carcinoma
pp. 143-147(5)
Author: Colombo, Massimo

New drugs for the treatment of hepatocellular carcinoma
pp. 148-158(11)
Authors: Boucher, Eveline; Forner, Alejandro; Reig, Maria; Bruix, Jordi

< previous issue | next issue > | all issues

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A